Abstract
Solid lipid nanoparticles (SLN™) are a new generation of drug delivery systems being exploited for several drugs since the nineties. These particles can be composed of different types of solid lipids, such as glycerides, waxes, and fatty acids, and stabilized by a wide range of surfactants. In the present chapter, the chemical structure, production methodology, and physicochemical characterization are systematically discussed. Parameters such as particle size, distribution, polymorphic behaviour, and crystallization are required to characterize SLN and may predict their in vitro stability and in vivo profile, therefore structural parameters can influence the biopharmaceutical properties. The use of SLN for drug delivery is also dependent on their toxicological profile in vitro. Nanotoxicology is also discussed addressing the key points that may limit the clinical use of SLN.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aditya NP et al (2010) Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activity. Eur J Pharm Sci 40(5):448–455
Aji Alex MR et al (2011) Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 42(1–2):11–18
Almeida AJ, Souto E (2007) Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 59(6):478–490
Almeida AJ, Runge S, Müller RH (1997) Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm 149(2):255–265
Ann PD (2004) Development of nanotechnologies. Mater Today 7(12 suppl):30–35
Araújo J et al (2009) Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomed Nanotechnol Biol Med 5(4):394–401
Attama AA, Müller-Goymann CC (2008) Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf, A Physicochem Eng Asp 315(1–3):189–195
Attama AA, Reichl S, Muller-Goymann CC (2009) Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. Curr Eye Res 34:698–705
Barber TA (1993) Pharmaceutical particulate matter: analysis and control. Interpharm Press, Buffalo Grove, IL
Başaran E et al (2010) Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 27(1):37–47
Battaglia L, Gallarate M (2012) Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Exp Opin Drug Deliv 9:497–508
Battaglia L et al (2010) Solid lipid nanoparticles produced through a coacervation method. J Microencapsul 27(1):78–85
Berne BJ, Pecora R (2000) Dynamic light scattering: with applications to chemistry, biology, and physics. Wiley, Mineola
Bhargava R, Levin IW (2001) Fourier transform infrared imaging: theory and practice. Anal Chem 73:5157–5167
Blasi P et al (2007) Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev 59(6):454–477
Blasi P et al (2011) Lipid nanoparticles for brain targeting I. Formulation optimization. Int J Pharm 419(1–2):287–295
Bunjes H (2005) Characterization of solid lipid nano- and microparticles. In: Nastruzzi C (ed) Lipospheres in drug targets and delivery. CRC Press, Florida
Bunjes H, Unruh T (2007) Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev 59(6):379–402
Bunjes H, Koch MHJ, Westesen K (2003) Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J Pharm Sci 92(7):1509–1520
Carbone C et al (2012) Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. Eur J Med Chem 49:110–117
Cavadas M, González-Fernández Á, Franco R (2011) Pathogen-mimetic stealth nanocarriers for drug delivery: a future possibility. Nanomed Nanotechnol Biol Med 7(6):730–743
Cavalli R et al (2002) Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238(1–2):241–245
Cengiz E et al (2006) Sunblocking efficiency of various TiO(2)-loaded solid lipid nanoparticle formulations(1). Int J Cosmet Sci 28(5):371–378
Christian GD, O’Reilly JE (1986) Instrumental analysis, 2nd edn. Allyn & Bacon, Boston
Corrias F, Lai F (2011) New methods for lipid nanoparticles preparation. Recent Pat Drug Deliv Formul 5(3):212–213
Coutts-Lendon CA et al (2003) The use of FT-IR imaging as an analytical tool for the characterization of drug delivery systems. J Control Release 93(3):223–248
Cui Z, Qiu F, Sloat BR (2006) Lecithin-based cationic nanoparticles as a potential DNA delivery system. Int J Pharm 313(1–2):206–213
Das S et al (2011) Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B: Biointerfaces 88(1):483–489
del Pozo-Rodríguez A et al (2008) Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. Int J Pharm 360(1–2):177–183
del Pozo-Rodríguez A et al (2010) Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration. Int J Pharm 385(1–2):157–162
Dhont JKG (2001) An Introduction to Dynamics of Colloids Volume 2 in: Colloid and Surface Chemistry- Studies in Interface Science, Möbius D, Miller R (eds). Elsevier Science B. V. Amsterdam
Doktorovova S et al (2010) Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B: Biointerfaces 75(2):538–542
Doktorovova S et al (2011) Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies. Int J Pharm 420(2):341–349
Doktorovova S et al (2012) Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN). Eur J Pharm Sci 45:606–612
Dong X, Mumper RJ (2006) The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase. Drug Dev Ind Pharm 32(8):973–980
Dong Y et al (2012) Solid lipid nanoparticles: continuous and potential large-scale nanoprecipitation production in static mixers. Colloids Surf B: Biointerfaces 94:68–72
Dowling A et al (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. The Royal Society and the Royal Academy of Engineering, London
Dreher F et al (1997) Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 45(2):131–140
Dubes A et al (2003) Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm 55(3):279–282
Eshel G et al (1991) Critical evaluation of the use of laser diffraction for particle-size distribution analysis. Soil Sci Soc Am J 68(3):736–743
Fangueiro J et al (2012) Thermodynamic behaviour of lipid nanoparticles upon delivery of vitamin E derivatives into the skin: in vitro studies. J Thermal Analysis Calorim 108:275–282
Fangueiro JF et al (2013) A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing. Pharm Dev Technol 18:545–549
Souza, A.L. et al (2012) Loading of praziquantel in the crystal lattice of solid lipid nanoparticles: Studies by DSC and SAXS. J Thermal Analysis Calorim 108:353–360
Filion MC, Phillips NC (1997) Anti-inflammatory activity of cationic lipids. Br J Pharmacol 122(3):551–557
Fontana G et al (2005) Preparation, characterization and in vitro antitumoral activity of solid lipid nanoparticles (SLN) containing tamoxifen. Drug Deliv 12(6):385–392
Ford JL, Mann TE (2012) Fast-Scan DSC and its role in pharmaceutical physical form characterisation and selection. Adv Drug Deliv Rev 64:422–430
Friedrich H et al (2010) Imaging of self-assembled structures: interpretation of TEM and cryo-TEM images. Angew Chem Int 49:7850–7858
Garcia-Fuentes M, Torres MR, Alonso JM (2002) Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B: Biointerfaces 27:159–168
Gasco MR (1997) Solid lipid nanospheres from warm microemulsion. Pharm Tech Eur 9:52–58
Geisse NA (2009) AFM and combined optical techniques. Mater Today 12(7–8):40–45
Gethner JS, Gaskin F (1978) Dynamic light scattering from solutions of microtubules. Biophys J 24:505–515
Ghadiri M et al (2012) Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm 424(1–2):128–137
Gill P, Moghadam TT, Ranjbar B (2010) Differential scanning calorimetry techniques: applications in biology and nanoscience. J Biomol Tech 21(4):167–193
Gokce EH et al (2008) Cyclosporine a loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm 364(1):76–86
Harms M, Müller-Goymann CC (2011) Solid lipid nanoparticles for drug delivery. J Drug Del Sci Tech 21(1):89–99
Heike B (2011) Structural properties of solid lipid based colloidal drug delivery systems. Curr Opin Colloid Interface Sci 16(5):405–411
Heurtault B et al (2002) A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19(6):875–880
Heurtault B et al (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials 24(23):4283–4300
Hiemenz PC, Rajagopalan R (1997) Principles of colloid and surface chemistry, 3rd edn. Marcel Dekker, New York
Hu FQ et al (2002) Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 239(1–2):121–128
Jenknins R (2000) X-ray techniques: overview. In: Meyers RA (ed) Encyclopedia of analytical chemistry. Wiley, Chichester, pp 1–20
Jenning V, Gohla S (2000) Comparison of wax and glyceride solid lipid nanoparticles (SLN®). Int J Pharm 196(2):219–222
Kalam MA et al (2010) Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J Drug Target 18(3):191–204
Kaneko F (2001) Polymorphism and phase transitions of fatty acids and acylglycerols. In: Garti N, Sato K (eds) Crystallization processes in fats and lipid systems. Marcel Dekker, New York, pp 53–98
Kheradmandnia S et al (2010) Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomed Nanotechnol Biol Med 6(6):753–759
Kim B-D, Na K, Choi H-K (2005) Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur J Pharm Sci 24(2–3):199–205
Krakty O (1982) Part I- A Survey in Small Angle X-Ray Scattering, Glatter O, Krakty O (eds). Academic Press Inc., London p 3–15
Kuntsche J, Horst JC, Bunjes H (2011) Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems. Int J Pharm 417:120–137
Kuo Y-C, Chen H-H (2009) Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int J Pharm 365(1–2):206–213
Kuo Y-C, Chung C-Y (2011) Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir. Colloids Surf B: Biointerfaces 88(2):682–690
Kuo Y-C, Lin C-W (2009) Effect of electromagnetic field and surface modification on the electrical behavior of novel solid lipid nanoparticles covered with l-arginine. Colloids Surf B: Biointerfaces 71(1):45–51
Kuo Y-C, Wang C-C (2010) Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: effect of surfactant composition. Colloids Surf B: Biointerfaces 76(1):286–291
Liu J et al (2008) Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 356(1–2):333–344
Lu W et al (2008) The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice. Int J Biol Macromol 43(3):320–324
Ma Z et al (2000) New developments in particle characterization by laser diffraction: size and shape. Powder Technol 111(1–2):66–78
Manjunath K, Venkateswarlu V (2005) Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 107(2):215–228
Martins S et al (2012) Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles. Eur J Pharm Sci 45:613–623
McCauley JA, Brittain HG (1995) Thermal methods of analysis. In: Brittain HG (ed) Physical characterization of pharmaceutical solids. Marcel Dekker, New York, pp 224–250
McElhaney RN (1982) The use of differential scanning calorimetry and differential thermal analysis in studies of model and biological membranes. Chem Phys Lipids 30(2–3):229–259
Mishra B, Patel BB, Tiwari S (2010) Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine 6(1):9–24
Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53(2):283–318
Mrsny RJ (2012) Perspective: oral drug delivery research in Europe. J Control Release 161:247–253
Mühlen AZ et al (1996) Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res 13(9):1411–1416
Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 50(1):161–177
Müller RH et al (2008) Cyclosporine-loaded solid lipid nanoparticles (SLN®): drug–lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm 68(3):535–544
Muller-Goymann CC (2004) Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 58(2):343–356
Nassimi M et al (2010) A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 75(2):107–116
Neubert RHH (2011) Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm 77(1):1–2
Noack A, Hause G, Mäder K (2012) Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. Int J Pharm 423:440–451
Olbrich C et al (2001) Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Release 77(3):345–355
Olbrich C, Kayser O, Müller RH (2002) Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)—effect of surfactants, storage time and crystallinity. Int J Pharm 237(1–2):119–128
Pandey R, Khuller GK (2005) Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 85(4):227–234
Patel PA, Patravale VB (2011) AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. J Biomed Nanotechnol 7(5):632–639
Pedersen N et al (2006) Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 62(2):155–162
Petersen S et al (2011) The physical state of lipid nanoparticles influences their effect on in vitro cell viability. Eur J Pharm Biopharm 79(1):150–161
Quintanar-Guerrero D et al (1999) Pseudolatex preparation using a novel emulsion–diffusion process involving direct displacement of partially water-miscible solvents by distillation. Int J Pharm 188(2):155–164
Rahman Z, Zidan AS, Khan MA (2010) Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm 76(1):127–137
Renliang X (2008) Progress in nanoparticles characterization: sizing and zeta potential measurement. Particuology 6(2):112–115
Rosen MJ (2004) Surfactants and interfacial phenomena, 3rd edn. Wiley, New Jersey
Sandri G et al (2010) Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems. J Microencapsul 27(8):735–746
Sanna V, Caria G, Mariani A (2010) Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of Econazole nitrate. Powder Technol 201(1):32–36
Sant S et al (2012) Microfabrication technologies for oral drug delivery. Adv Drug Deliv Rev 64:496–507
Sarmento B et al (2011) Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system. Carbohydr Polym 84(3):919–925
Schubert MA, Muller-Goymann CC (2005) Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm 61(1–2):77–86
Schubert MA, Harms M, Müller-Goymann CC (2006) Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm Sci 27(2–3):226–236
Severino P et al (2011) Polymorphism, crystallinity and hydrophilic–lipophilic balance of stearic acid and stearic acid–capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids Surf B: Biointerfaces 86(1):125–130
Severino P et al (2012) Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliv 2012:750891
Shahgaldian P et al (2003) AFM imaging of calixarene based solid lipid nanoparticles in gel matrices. Eur J Pharm Biopharm 55(1):107–113
Sinha VR et al (2011) Solid lipid nanoparticles (SLN´s)—trends and implications in drug targeting. Int J Adv Pharm Sci 1:212–238
Sivaramakrishnan R et al (2004) Glucocorticoid entrapment into lipid carriers—characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release 97(3):493–502
Sjöström B, Bergenstahl B (1992) Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholestreryl acetate. Int J Pharm 88:53–62
Souto EB, Doktorovova S (2009) Chapter 6—solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery. Methods Enzymol 464:105–129
Souto EB, Müller RH (2005) The use of SLN® and NLC® as topical particulate carriers for imidazole antifungal agents. Die Pharmazie 61(5):431–437
Souto EB, Muller RH (2006) Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul 23:377–388
Souto EB, Müller RH (2007) Lipid nanoparticles (SLN and NLC) for drug delivery. In: Domb J et al (eds) Nanoparticles for pharmaceutical applications. American Scientific Publishers, Los Angeles, CA, pp 103–122
Souto EB, Muller RH (2010) Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol 197:115–141
Souto EB, Muller RH (2011) Solid lipid nanoparticles and nanostructures lipid carriers—lipid nanoparticles for medicals and pharmaceuticals. Encyclopedia Nanosci Nanotechnol 23:313–328
Souto EB et al (2004a) Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations. J Cosmet Sci 55:463–471
Souto EB et al (2004b) Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm 58(1):83–90
Souto EB, Mehnert W, Müller RH (2006) Polymorphic behaviour of Compritol 888 ATO as bulk lipid and as SLN and NLC. J Microencapsul 23(4):417–433
Souto EB et al (2011a) Lipid-based nanocarriers for cutaneous administration of pharmaceutics. Encyclopedia Nanosci Nanotechnol 15:479–491
Souto EB, Doktorovova S, Boonme P (2011b) Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations. J Drug Del Sci Tech 21(1):43–54
Sznitowska M et al (2001) Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur J Pharm Biopharm 52(2):159–163
Tabatt K et al (2004) Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes. J Control Release 97(2):321–332
Venishetty VK et al (2012) Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf B: Biointerfaces 95:1–9
Videira MA et al (2002) Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 10(8):607–613
Videira M, Almeida AJ, Fabra À (2012) Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomed Nanotechnol Biol Med 8:1208–1215
Vieira V et al (2012) Characterization of the physicochemical performance of nimesulide-loaded lipid nanoparticulates. In: Third scientific meeting of the institute for biotechnology and bioengineering. Lisbon, Portugal
Vighi E et al (2007) Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm 67(2):320–328
Vighi E et al (2010) PDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles. Int J Pharm 389(1–2):254–261
Westesen K, Siekmann B, Koch MHJ (1993) Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int J Pharm 93(1–3):189–199
Westesen K, Bunjes H, Koch MHJ (1997) Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48(2–3):223–236
Wiechers J, Souto EB (2010) Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as novel delivery systems for cosmetic actives. Part I. Cosmet Toiletries 10:22–30
Wissing SA, Kayser O, Muller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56(9):1257–1272
Yang W, Peters JI, Williams RO III (2008) Inhaled nanoparticles—a current review. Int J Pharm 356(1–2):239–247
Yoo J-W, Doshi N, Mitragotri S (2011) Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliv Rev 63(14–15):1247–1256
Zhang Q et al (2000) Studies on the cyclosporin A loaded stearic acid nanoparticles. Int J Pharm 200(2):153–159
Zhang S-H et al (2008) Preparation of solid lipid nanoparticles in co-flowing microchannels. Chem Eng J 144(2):324–328
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Souto, E.B., Fangueiro, J.F., Müller, R.H. (2013). Solid Lipid Nanoparticles (SLN™). In: Uchegbu, I., Schätzlein, A., Cheng, W., Lalatsa, A. (eds) Fundamentals of Pharmaceutical Nanoscience. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9164-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9164-4_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9163-7
Online ISBN: 978-1-4614-9164-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)